Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Hui-Kuo G. Shu, MD, PhD
Ultima Vez Modificado: 29 de septiembre del 2002
Dear OncoLink "Ask The Experts,"
My 20-month-old son was recently diagnosed with a pilocytic astrocytoma attached to his brain stem. The tumor was explained to me as being mildly malignant with a possibility of becoming more aggressive. During his surgery 2/3 of the tumor was removed. My question is; of the remaining tumor, are there any studies that show the percentage of this astrocytoma becoming more aggressive (more malignant)?
Hui-Kuo G. Shu, MD, PhD, Assistant Professor in the Department of Radiation Oncology at the University of Pennsylvania, responds:
Your son has a pilocytic astrocytoma that had a significant portion resected (surgically removed). Pilocytic astrocytomas are considered the lowest grade astrocytomas (least aggressive). They tend to be well-circumscribed and, depending on the location, can often be completely resected (which is generally considered to be curative). However, some locations, such as in the brainstem, are more difficult to resect completely because of potential morbidity associated with a highly aggressive surgical approach. In this situation where a subtotal resection is performed, a significant risk of tumor progression exists. If there were a recurrence, the great majority of these would continue to be pilocytic at recurrence. However, as your son's physicians have correctly informed you, the possibility exists for malignant transformation at progression. The probability of this occurring is very low with an estimated incidence of 0.9% based on a study of 107 patients with cerebellar pilocytic astrocytoma by a group at the Mayo Clinic (Tomlinson et al., J Child Neurol 9:301-10, 1994). Therefore, while malignant transformation can happen, it is very rare.
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults